Description

Rabies Virus Glycoprotein CAS NO 115136-25-9 is a purified, recombinant protein derived from the surface of the rabies virus. This glycoprotein is the primary antigen responsible for inducing a protective immune response, making it a critical component for vaccine development and immunological research. It is essential for researchers and manufacturers in the biopharmaceutical and diagnostic industries focused on rabies prevention, serological testing, and antiviral drug discovery.

Application

• Vaccine Development & Research: Key antigen for the development and evaluation of next-generation rabies vaccines, including subunit and recombinant vector vaccines.
• Immunoassay Production: Used as a coating antigen or standard in ELISA kits and other serological assays to detect rabies virus antibodies.
• Antiviral Studies: Employed in research to study virus-host cell interactions, neutralization mechanisms, and to screen for potential antiviral compounds.
• Diagnostic Reference Standard: Serves as a purified reference material for quality control and standardization of diagnostic tests.
• Immunogenicity Studies: Utilized in animal models to assess the potency and efficacy of vaccine candidates and adjuvants.
• Biochemical Research: Fundamental tool for studying glycoprotein structure, function, and post-translational modifications.

Basic Information

Product Name	Rabies Virus Glycoprotein
CAS No.	115136-25-9
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Rabies Glycoprotein; Rabies Virus G Protein; RVG; RABV-G; Rabies Virus Surface Glycoprotein; Rabies Virus Antigen; Lyssa Virus Glycoprotein
EINECS	Contact for details

Quality Control

Our Rabies Virus Glycoprotein is produced and tested under stringent quality management systems. Each batch is characterized for identity, purity, and biological activity using advanced analytical techniques. Certificates of Analysis (COA) detailing specifications such as purity (by SDS-PAGE and HPLC), endotoxin levels, and protein concentration are provided to ensure compliance with research and development standards.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store frozen at -20°C or below. Avoid repeated freeze-thaw cycles. The product is hygroscopic (moisture-sensitive); allow the vial to equilibrate to room temperature before opening to prevent condensation.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or clear solution
Identification (SDS-PAGE/Western Blot)	Corresponds to Rabies Virus Glycoprotein
Purity (SDS-PAGE)	> 90%
Purity (HPLC)	> 95%
Protein Content	≥ 1 mg/vial (lot-specific)
Endotoxin	< 1.0 EU/µg
Biological Activity	Confirmed by ELISA or cell-based assay
Solubility	Soluble in PBS or suitable aqueous buffer

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.